US Patent 9848587 Humanized T cell co-receptor mice
Patent 9848587 was granted and assigned to Regeneron Pharmaceuticals on December, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 22 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+337 characters)
Article
Patent abstract
The invention provides genetically modified non-human animals that express chimeric human/non-human T cell co-receptor polypeptides (e.g., CD4, CD8α, CD8β), as well as embryos, cells, and tissues comprising the same. Also provided are constructs for making said genetically modified animals and methods of making the same.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Andrew J. Murphy0
Cagan Gurer0
Lynn Macdonald0
Naxin Tu0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09848587 Humanized T cell co-receptor mice US Patent 9848587 Humanized T cell co-receptor mice
Infobox
Patent Number
098485870
Patent Number
98485870
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098485870
Date of Patent
December 26, 2017
0Patent Application Number
141853010
Date Filed
February 20, 2014
0Patent Primary Examiner
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09848587 Humanized T cell co-receptor mice
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09848587
Date of patent
December 26, 2017
Patent application number
14185301
Date Filed
February 20, 2014
Patent primary examiner
Find more entities like US Patent 9848587 Humanized T cell co-receptor mice
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.